ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
3 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
1.2K
|
342K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Five TAVR Patients Successfully Implanted With DurAVR Valve
|
|
centro11
|
140 |
50K |
3 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
140
|
50K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Five TAVR Patients Successfully Implanted With DurAVR Valve
|
|
centro11
|
140 |
50K |
6 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
140
|
50K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Five TAVR Patients Successfully Implanted With DurAVR Valve
|
|
centro11
|
140 |
50K |
2 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
140
|
50K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Five TAVR Patients Successfully Implanted With DurAVR Valve
|
|
centro11
|
140 |
50K |
1 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
140
|
50K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Five TAVR Patients Successfully Implanted With DurAVR Valve
|
|
centro11
|
140 |
50K |
2 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
140
|
50K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notification of cessation of securities - AVR
|
|
centro11
|
8 |
3.5K |
0 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
8
|
3.5K
|
0
|
|
ASX - By Stock
|
ESR |
Re:
Ann: Response to ASX Price Query
|
|
centro11
|
59 |
15K |
10 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
59
|
15K
|
10
|
|
Charts
|
EVG |
Re:
BEM Chart
|
|
centro11
|
208 |
51K |
1 |
12/01/22 |
12/01/22 |
Charts
|
208
|
51K
|
1
|
|
Charts
|
EVG |
Re:
BEM Chart
|
|
centro11
|
208 |
51K |
2 |
11/01/22 |
11/01/22 |
Charts
|
208
|
51K
|
2
|
|
Charts
|
EVG |
Re:
BEM Chart
|
|
centro11
|
208 |
51K |
2 |
11/01/22 |
11/01/22 |
Charts
|
208
|
51K
|
2
|
|
Charts
|
EVG |
Re:
BEM Chart
|
|
centro11
|
208 |
51K |
2 |
11/01/22 |
11/01/22 |
Charts
|
208
|
51K
|
2
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
5 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
1.2K
|
342K
|
5
|
|
ASX - By Stock
|
CAZ |
Re:
Cazaly 2022
|
|
centro11
|
37 |
8.2K |
1 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
37
|
8.2K
|
1
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
13 |
09/01/22 |
09/01/22 |
ASX - By Stock
|
1.2K
|
342K
|
13
|
|
Charts
|
EVG |
Re:
BEM Chart
|
|
centro11
|
208 |
51K |
3 |
07/01/22 |
07/01/22 |
Charts
|
208
|
51K
|
3
|
|
Charts
|
EVG |
Re:
BEM Chart
|
|
centro11
|
208 |
51K |
2 |
06/01/22 |
06/01/22 |
Charts
|
208
|
51K
|
2
|
|
Charts
|
EVG |
Re:
BEM Chart
|
|
centro11
|
208 |
51K |
2 |
06/01/22 |
06/01/22 |
Charts
|
208
|
51K
|
2
|
|
Charts
|
EVG |
Re:
BEM Chart
|
|
centro11
|
208 |
51K |
1 |
05/01/22 |
05/01/22 |
Charts
|
208
|
51K
|
1
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
5 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
1.2K
|
342K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR First in Human Patient Study Follow Up
|
|
centro11
|
57 |
20K |
5 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
57
|
20K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
AVRO
|
|
centro11
|
422 |
109K |
1 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
422
|
109K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Managing Director Update
|
|
centro11
|
341 |
105K |
1 |
30/12/21 |
30/12/21 |
ASX - By Stock
|
341
|
105K
|
1
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
1 |
30/12/21 |
30/12/21 |
ASX - By Stock
|
1.2K
|
342K
|
1
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
1 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
1.2K
|
342K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
merry xmas and still here
|
|
centro11
|
60 |
20K |
11 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
60
|
20K
|
11
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
4 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
1.2K
|
342K
|
4
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
0 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
1.2K
|
342K
|
0
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
0 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
1.2K
|
342K
|
0
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
1 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
1.2K
|
342K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AVRO
|
|
centro11
|
422 |
109K |
1 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
422
|
109K
|
1
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
0 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
1.2K
|
342K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
AVRO
|
|
centro11
|
422 |
109K |
1 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
422
|
109K
|
1
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
1 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
1.2K
|
342K
|
1
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
1 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
1.2K
|
342K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Repayment of Facility Agreement
|
|
centro11
|
36 |
10K |
4 |
18/12/21 |
18/12/21 |
ASX - By Stock
|
36
|
10K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
AVRO
|
|
centro11
|
422 |
109K |
2 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
422
|
109K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AVRO
|
|
centro11
|
422 |
109K |
0 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
422
|
109K
|
0
|
|
ASX - By Stock
|
CAZ |
Re:
Ann: Ashburton Field Work Commences
|
|
centro11
|
27 |
7.2K |
0 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
27
|
7.2K
|
0
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
5 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
1.2K
|
342K
|
5
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
3 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
1.2K
|
342K
|
3
|
|
ASX - By Stock
|
EVG Graphite |
Re:
General Discussion
|
|
centro11
|
1.2K |
342K |
2 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
1.2K
|
342K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AVRO
|
|
centro11
|
422 |
109K |
0 |
11/12/21 |
11/12/21 |
ASX - By Stock
|
422
|
109K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC Commences Proceedings Against ISX and JK
|
|
centro11
|
2.6K |
890K |
0 |
11/12/21 |
11/12/21 |
ASX - By Stock
|
2.6K
|
890K
|
0
|
|
ASX - By Stock
|
EVG |
Re:
Ann: Positive Updated Scoping Study Presentation
|
|
centro11
|
69 |
11K |
2 |
10/12/21 |
10/12/21 |
ASX - By Stock
|
69
|
11K
|
2
|
|
ASX - By Stock
|
CAZ |
Re:
Ann: WML:Nickel and Copper Massive Sulphides confirmed at Mt Venn
|
|
centro11
|
13 |
4.2K |
1 |
10/12/21 |
10/12/21 |
ASX - By Stock
|
13
|
4.2K
|
1
|
|
ASX - By Stock
|
EVG |
Re:
Ann: Positive Updated Scoping Study Presentation
|
|
centro11
|
69 |
11K |
3 |
10/12/21 |
10/12/21 |
ASX - By Stock
|
69
|
11K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
ISX & ISXFEU
|
|
centro11
|
137 |
60K |
1 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
137
|
60K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC Commences Proceedings Against ISX and JK
|
|
centro11
|
2.6K |
890K |
8 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
2.6K
|
890K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change of Director's Interest Notice
|
|
centro11
|
13 |
3.7K |
3 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
13
|
3.7K
|
3
|
|